video-assisted thoracoscopic sympathectomy

  • 文章类型: Journal Article
    对于手汗症(PHH)患者,使用电视胸腔镜交感神经切除术(VATS)进行射频消融(RFA)治疗的长期疗效比较尚不确定。本研究旨在比较RFA和VATS在PHH患者中的疗效和安全性。我们从中国14个中心招募了年龄≥14岁的诊断为PHH的患者。RFA或VATS的治疗选择被分配到PHH患者的两个队列。主要结果是1年时的疗效。总共招募了807名患者。在倾向得分匹配后,RFA组的完全缓解率低于VATS组(95%CI0.21-0.57;p<0.001)。然而,手掌干燥率(95%CI0.38-0.92;p=0.020),术后疼痛(95%CI0.13-0.33;p<0.001),与手术相关的并发症(95%CI0.19-0.85;p=0.020)在RFA组低于VATS组,但RFA组皮肤温度升高更常见(95%CI1.84-3.58;p<0.001)。对于PHH的完全缓解,RFA的成功率低于VATS。然而,与接受VATS的患者相比,接受RFA的患者的症状负担和费用较低.试用注册:ChiCTR2000039576,URL:http://www。chictr.org.cn/index。aspx.
    Radiofrequency ablation (RFA) comparative efficacy of treatments using video-assisted thoracoscopic sympathectomy (VATS) in the long term remains uncertain in patients with palmar hyperhidrosis (PHH). This study aimed to compare the efficacy and safety of RFA and VATS in patients with PHH. We recruited patients aged ≥ 14 years with diagnosed PHH from 14 centres in China. The treatment options of RFA or VATS were assigned to two cohort in patients with PHH. The primary outcome was the efficacy at 1-year. A total of 807 patients were enrolled. After propensity score matching, the rate of complete remission was lower in RFA group than VATS group (95% CI 0.21-0.57; p < 0.001). However, the rates of palmar dryness (95% CI 0.38-0.92; p = 0.020), postoperative pain (95% CI 0.13-0.33; p < 0.001), and surgery-related complications (95% CI 0.19-0.85; p = 0.020) were lower in RFA group than in VATS group, but skin temperature rise was more common in RFA group (95% CI 1.84-3.58; p < 0.001). RFA had a lower success rate than VATS for the complete remission of PHH. However, the symptom burden and cost are lower in patients undergoing RFA compared to those undergoing VATS.Trial Registration: ChiCTR2000039576, URL: http://www.chictr.org.cn/index.aspx .
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    内窥镜胸交感神经切除术治疗原发性手掌多汗症后的术后膈疝(DH)极为罕见。我们介绍了一名21岁的女性患者,该患者在接受双侧电视胸腔镜交感神经切除术R4消融后的第一天出现了左DH,并出现了胃疝和胃穿孔。她抱怨严重的呼吸困难和胸痛,紧急胸部X光和计算机断层扫描显示左侧胸腔积液,萎陷的肺,离开DH,让胃突出到胸部.进行了紧急胸腔镜手术。我们在术中修复了the肌缺损,并用胸野的腹膜腔代替了胃。患者出院,无并发症。在3个月的随访中,她没有出现复发症状。当患者在交感神经切除术后抱怨胃肠道或呼吸道症状时,应考虑术后DH。虽然它是非常罕见的。
    Postoperative diaphragmatic hernia (DH) following endoscopic thoracic sympathectomy for primary palmar hyperhidrosis is extremely rare. We present a 21-year-old female patient who developed a left DH with herniation of the stomach and gastric perforation on the first postoperative day after undergoing bilateral video-assisted thoracoscopic sympathectomy R4 ablation. She complained of severe dyspnea and chest pain, and an emergency chest x-ray and computed tomography revealed left pleural effusion, collapsed lung, and left DH, which allowed the stomach to herniate into the chest. Emergency thoracoscopic surgery was performed. We repaired the diaphragmatic defect intraoperatively and replaced the stomach with the peritoneal cavity from the thoracic field. The patient was discharged without complications. She did not present with recurrent symptoms at the 3-month follow-up. Postoperative DH should be considered when patients complain of gastrointestinal or respiratory symptoms after sympathectomy, although it is very rare.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:本研究旨在调查有效性,三种不同的电视胸腔镜交感神经切除术治疗原发性局灶性多汗症的成功率和并发症率;切除,烧灼和剪裁。
    方法:我们回顾性评估了60例患者(33例男性,27名女性;平均年龄25.1±6.4岁;范围16至43岁),患有原发性局灶性多汗症,并在2010年1月至2013年12月期间接受了电视胸腔镜交感神经切除术。在同一疗程中对患者进行双侧治疗:从20例患者的T2-T4脊髓段切除交感神经链和神经节(第1组),烧灼20例患者(第2组),并夹住20例患者(第3组)。比较各组的手术成功率和并发症发生率。
    结果:所有患者均成功行交感神经切除术。发现2组(42.5±7.1分钟)和3组(36.9±7.8分钟)的平均手术时间明显缩短,与第1组相比(51.1±8.4分钟)(p<0.05)。代偿性多汗症在17例患者(28.3%)中发展,在所有组之间具有可比性(p<0.05)。
    结论:我们的研究结果表明,切除,烧灼,夹闭是治疗原发性局灶性多汗症的有效和可靠的方法。根据我们的经验,我们认为视频辅助下的交感神经切除术可能是治疗原发性局灶性多汗症的首选方法.
    BACKGROUND: This study aims to investigate the effectiveness, success and complication rates of three different video-assisted thoracoscopic sympathectomy procedures performed for the treatment of primary focal hyperhidrosis; excision, cauterization and clipping.
    METHODS: We retrospectively evaluated the records of 60 patients (33 males, 27 females; mean age 25.1±6.4 years; range 16 to 43 years) with primary focal hyperhidrosis and treated with videoassisted thoracoscopic sympathectomy between January 2010 and December 2013. The patients were treated bilaterally at the same session: the sympathetic chain and ganglia were excised from the spinal cord segments of T2-T4 in 20 patients (group 1), cauterized in 20 patients (group 2), and clipped in 20 patients (group 3). The procedural success and complication rates were compared among the groups.
    RESULTS: Sympathectomy was successfully performed in all patients. The mean operation time was found to be significantly shorter in group 2 (42.5±7.1 min) and group 3 (36.9±7.8 min), compared to group 1 (51.1±8.4 min) (p<0.05). Compensatory hyperhidrosis developed in 17 patients (28.3%) and was comparable among all groups (p<0.05).
    CONCLUSIONS: Our study results suggest that excision, cauterization, and clipping are effective and reliable in the treatment of primary focal hyperhidrosis. Based on our experience, we believe that sympathectomy with video-assisted excision may be preferable for the treatment of primary focal hyperhidrosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:内窥镜胸交感神经切除术是目前原发性上肢多汗症的最佳治疗方法,但是潜在的不良影响,特别是补偿性出汗的发展,是一个令人担忧的问题,通常排除手术作为一种确定的治疗方法。本研究旨在评估两阶段单侧和一阶段双侧胸腔镜交感神经切除术的长期结果。
    方法:从1995年11月至2011年2月,261例严重手掌和/或腋窝多汗症患者接受了内镜下交感神经切除术,随访至少4年。一百二十六名患者接受了一期双侧治疗,单孔电视胸腔镜交感神经切断术(一期组),135例患者接受了两期单侧,单端口电视胸腔镜交感神经切除术,手术之间的平均时间间隔为四个月(两阶段组)。
    结果:术后平均随访时间为7.2年(范围,4-9年)。一阶段组中有16例患者(12.7%),两阶段组中有15例患者(11.1%)患有心动过缓(P=0.15)。复发发生在一个阶段组中的三名患者(2.4%)和两个阶段组中的一名(0.7%)(P=0.09)。一阶段组8例(6.3%)和两阶段组11例(8.1%)发生面部潮红或热疗。在一阶段组中有27例患者(21.4%)发生代偿性出汗,在两阶段组中有6例患者(4.4%)发生代偿性出汗(P=0.0001)。然而,在随访期间,两阶段组中有5例患者(83.3%)恢复了代偿性出汗,一阶段组中有9例(33.35%)(Log-rank检验P=0.016;HR,7.196;95%CI,1.431-36.20)。一阶段组中至少有90%的患者在手术后三年观察到术后生活质量(QoL)评分改善,两阶段组中至少有95%的患者(P=0.001)。
    结论:对于手汗症和腋窝多汗症患者,在两阶段单侧和一阶段双侧交感神经切除术后,代偿性出汗似乎在随访期间得到改善,恢复率更高。
    BACKGROUND: Endoscopic thoracic sympathectomy is currently the best treatment for primary upper extremity hyperhidrosis, but the potential for adverse effects, particularly the development of compensatory sweating, is a concern and often precludes surgery as a definitive therapy. This study aims to evaluate long-term results of two-stage unilateral versus one-stage bilateral thoracoscopic sympathectomy.
    METHODS: From November 1995 to February 2011, 261 patients with severe palmar and/or axillary hyperhidrosis underwent endoscopic sympathectomy with a follow-up of at least 4 years. One-hundred and twenty-six patients received one-stage bilateral, single port video-assisted thoracoscopic sympathectomy (one-stage group) and 135 patients underwent two-stage unilateral, single-port video-assisted thoracoscopic sympathectomy, with a mean time interval of four months between the procedures (two-stage group).
    RESULTS: The mean postoperative follow-up period was 7.2 years (range, 4-9 years). Sixteen patients (12.7%) in the one-stage group and 15 patients (11.1%) in the two-stage group suffered from bradycardia (P=0.15). Recurrences occurred in three patients (2.4%) in the one-stage group and one (0.7%) in the two-stage group (P=0,09). Facial flushing or hyperthermia occurred in eight patients (6.3%) in the one-stage group and 11 (8.1%) of the two-stage group. Compensatory sweating occurred in 27 patients (21.4%) in the one-stage group and six patients (4.4%) in the two-stage group (P=0.0001). However, compensatory sweating recovered in five patients (83.3%) in the two-stage group versus nine (33.35%) in one-stage group during the follow-up period (Log-rank test P=0.016; HR, 7.196; 95% CI, 1.431-36.20). An improvement in postoperative quality of life (QoL) scores was observed in at least 90% of patients at three years after surgery in the one-stage group and at least 95% of patients in the two-stage group (P=0.001).
    CONCLUSIONS: Compensatory sweating seems to improve during the follow-up period with a higher recovery rate after two-stage unilateral versus one-stage bilateral sympathectomy for patients with palmar and axillary hyperhidrosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Comparative Study
    OBJECTIVE: Video-assisted thoracoscopic sympathectomy is currently the best treatment for palmar and axillary hyperhidrosis. It can be performed through either one or two stages of surgery. This study aimed to evaluate the operative and postoperative results of two-stage unilateral vs one-stage bilateral thoracoscopic sympathectomy.
    METHODS: From November 1995 to February 2011, 270 patients with severe palmar and/or axillary hyperhidrosis were recruited for this study. One hundred and thirty patients received one-stage bilateral, single-port video-assisted thoracoscopic sympathectomy (one-stage group) and 140, two-stage unilateral, single-port video-assisted thoracoscopic sympathectomy, with a mean time interval of 4 months between the procedures (two-stage group).
    RESULTS: The mean postoperative follow-up period was 12.5 (range: 1-24 months). After surgery, hands and axillae of all patients were dry and warm. Sixteen (12%) patients of the one-stage group and 15 (11%) of the two-stage group suffered from mild/moderate pain (P = 0.8482). The mean operative time was 38 ± 5 min in the one-stage group and 39 ± 8 min in the two-stage group (P = 0.199). Pneumothorax occurred in 8 (6%) patients of the one-stage group and in 11 (8%) of the two-stage group. Compensatory sweating occurred in 25 (19%) patients of the one-stage group and in 6 (4%) of the two-stage group (P = 0.0001). No patients developed Horner\'s syndrome.
    CONCLUSIONS: Both two-stage unilateral and one-stage bilateral single-port video-assisted thoracoscopic sympathectomies are effective, safe and minimally invasive procedures. Two-stage unilateral sympathectomy can be performed with a lower occurrence of compensatory sweating, improving permanently the quality of life in patients with palmar and axillary hyperhidrosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号